Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 1.86 · gapped above the open, never looked back. High/low 1.91 at 4:45 am ET, 1.90 at 4:00 am ET.
216 institutional managers report a position in Compass Therapeutics, Inc. worth $363.8M between them, filed on form 13F for the quarter ending 2026-06-30. 20 of them hold 80% of it, the largest being Tang Capital Management LLC at 10.83%.
191 more managers in the register
20 managers hold 80% of the $363.8M institutional base. The other 196 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
Compass Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
via Suvretta Capital Management, LLC, Orbimed Advisors LLC, Vivo Capital, LLC +2 more · 8.49% of CMPX, 9.59% of AVBP
via Orbimed Advisors LLC, Suvretta Capital Management, LLC, KVP Capital Advisors, LP +2 more · 9.16% of CMPX, 9.10% of WHWK
via Tang Capital Management LLC, Suvretta Capital Management, LLC, Palo Alto Investors, LLC · 10.83% of CMPX, 8.93% of CAPR
via Tang Capital Management LLC, Suvretta Capital Management, LLC, Qube Research & Technologies Ltd +4 more · 10.83% of CMPX, 8.15% of FULC
via Orbimed Advisors LLC, Enavate Sciences GP, LLC, Qube Research & Technologies Ltd +2 more · 9.16% of CMPX, 11.25% of UPB
via Orbimed Advisors LLC, Vivo Capital, LLC, Blue Owl Capital Holdings LP +2 more · 9.16% of CMPX, 9.83% of CRVS
Managers holding a meaningful stake in CMPX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
CMPX (Compass Therapeutics, Inc.) has 6 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.